Abstract
Protein fragment complementation assay (PCA) is based on the interaction between two protein partners (e.g. target antigen and antibody), which are genetically fused to the two halves of a dissected marker protein. Binding of the two partners reassembles the marker protein and hence reconstitutes its activity. In this work we have developed the first application of beta-lactamase-based PCA for the isolation of single chain Fv fragments (scFvs) binding to the human receptor RON from a naïve library. Specific scFvs with the ability to immunoprecipitate could be isolated after a single round of PCA selection from an scFv repertoire previously pre-selected by phage display. Furthermore, the PCA was used to successfully map the epitopes recognized by the selected scFvs by screening them against a small library of random RON fragments.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antibodies / genetics
-
Antibodies / immunology*
-
Antibodies / metabolism
-
Antibody Affinity / genetics
-
Antigens / genetics
-
Antigens / immunology
-
Antigens / metabolism
-
Cell Line
-
Epitope Mapping
-
Escherichia coli / genetics
-
Humans
-
Mice
-
Peptide Fragments / genetics
-
Peptide Fragments / immunology*
-
Peptide Fragments / metabolism
-
Peptide Library
-
Protein Array Analysis / methods*
-
Receptor Protein-Tyrosine Kinases / genetics
-
Receptor Protein-Tyrosine Kinases / immunology
-
Receptor Protein-Tyrosine Kinases / metabolism
-
Recombinant Fusion Proteins / genetics
-
Recombinant Fusion Proteins / immunology*
-
Recombinant Fusion Proteins / metabolism
-
Reproducibility of Results
-
Sequence Analysis, DNA
-
beta-Lactamases / genetics*
-
beta-Lactamases / metabolism
Substances
-
Antibodies
-
Antigens
-
Peptide Fragments
-
Peptide Library
-
Recombinant Fusion Proteins
-
RON protein
-
Receptor Protein-Tyrosine Kinases
-
beta-Lactamases